Complement activation by neutrophil granulocytes

Scandinavian Journal of Immunology

Volumn 67, Issue 4, 2008, Pages 354-361

  Asberg A E ^a,b   Mollnes, T E ^c,d   Videm, V ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORDLAND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LEPIRUDIN; PROTEIN INHIBITOR;

ARTICLE; CELL INTERACTION; CELL ISOLATION; CELL STIMULATION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; NEUTROPHIL; PRIORITY JOURNAL; THROMBOCYTE KINETICS;

COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLATELET ACTIVATION; SONICATION;

EID: 40849140981     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02077.x     Document Type: Article

References (29)

1. Walport MJ. Complement. First of two parts. N Engl J Med 2001 344 : 1058 66.
2. Mastellos D, Lambris JD. Complement: more than a 'guard' against invading pathogens? Trends Immunol 2002 23 : 485 91.
3. Pekna M, Nilsson L, Nilsson-Ekdahl K, Nilsson UR, Nilsson B. Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction. Clin Exp Immunol 1993 91 : 404 9.
4. Gu YJ, Mariani MA, Boonstra PW, Grandjean JG, van Oeveren W. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: the role of tissue injury by surgical incision. Chest 1999 116 : 892 8.
5. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003 75 : S715 20.
6. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997 112 : 676 92.
7. Rinder CS, Rinder HM, Johnson K et al. Role of C3 cleavage in monocyte activation during extracorporeal circulation. Circulation 1999 100 : 553 8.
8. Fung M, Loubser PG, Undar A et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 2001 122 : 113 22.
9. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997 96 : 3542.
10. Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today 1997 18 : 111 5.
11. Mollnes TE, Song WC, Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol 2002 23 : 61 4.
12. Bruins P, te Velthuis H, Eerenberg-Belmer AJ et al. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro. Thromb Haemost 2000 84 : 237 43.
13. Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000 105 : 1363 71.
14. Huber-Lang M, Sarma JV, Zetoune FS et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nature Med 2006 12 : 682 7.
15. Vogt W, Zimmermann B, Hesse D, Nolte R. Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents. Mol Immunol 1992 29 : 251 6.
16. Vogt W. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 2000 201 : 470 7.
17. Vogt W. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 1996 195 : 334 46.
18. Mollnes TE, Brekke OL, Fung M et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002 100 : 1869 77.
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968 97 : 77 89.
20. Fure H, Nielsen EW, Hack CE, Mollnes TE. A neoepitope-based enzyme immunoassay for quantification of C1- inhibitor in complex with C1r and C1s. Scand J Immunol 1997 46 : 553 7.
21. Wolbink GJ, Bollen J, Baars JW et al. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods 1993 163 : 67 76.
22. Garred P, Mollnes TE, Lea T. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988 27 : 329 35.
23. Mollnes TE. Analysis of in vivo complement activation. In : Herzenberg LA, Weir DM, Herzenberg LA, Blackwell C, eds. Weir's Handbook of Experimental Immunology. Boston, MA : Blackwell Science 1997 : 78.1 78.8.
24. Videm V. Heparin in clinical doses 'primes' granulocytes to subsequent activation as measured by myeloperoxidase release. Scand J Immunol 1996 43 : 385 90.
25. Hegnhøj J, Schaffalitzky de Muckadell OB. An enzyme-linked immunosorbent assay for measurement of lactoferrin in duodenal aspirates and other biological fluids. Scand J Clin Lab Invest 1985 45 : 489 95.
26. Conover WJ. Practical Nonparametric Statistics, 3rd edn. New York : Wiley, 1999.
27. Rosenkranz AR, Kormoczi GF, Thalhammer F et al. Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes. J Am Soc Nephrol 1999 10 : 128 35.
28. Huber-Lang M, Younkin EM, Sarma JV et al. Generation of C5a by phagocytic cells. Am J Pathol 2002 161 : 1849 59.
29. Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J Thromb Haemost 2006 4 : 2035 42.